Rheumatology International

Papers
(The median citation count of Rheumatology International is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review63
COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis55
Epidemiology and genetics of granulomatosis with polyangiitis55
Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR53
Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study51
Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases43
The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study38
Alternatives for erroneous finger probe pulse oximetry in systemic sclerosis patients during COVID-19 pandemic37
Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 201732
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review27
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis26
Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination26
Rehabilitative management of post-acute COVID-19: clinical pictures and outcomes23
Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development22
Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients22
The synergistic role of TNFA − 308G/A and IL10 − 1082A/G polymorphisms in ankylosing spondylitis21
Association of extended myositis panel results, clinical features, and diagnoses: a single-center retrospective observational study21
Coincidence of juvenile idiopathic arthritis and type 1 diabetes: a case-based review19
Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study19
Clinical presentation and treatment outcomes of arterial involvement in Behçet’s disease: a single-centre experience19
What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study18
Reactive arthritis after COVID-19: a case-based review16
Evaluation of the prevalence of musculoskeletal conditions in consecutive patients with skin psoriasis: a descriptive cross-sectional study16
A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient15
Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study13
The continuum of art and rheumatology: a discernment of mutual inclusivity13
Dosage of resistance exercises in fibromyalgia: evidence synthesis for a systematic literature review up-date and meta-analysis11
Non-disease specific patient-reported outcome measures of health-related quality of life in juvenile idiopathic arthritis: a systematic review of current research and practice11
Rituximab and intravenous immunoglobulin treatment in PM/Scl antibody-associated disease: case-based review11
The efficacy and safety of extracorporeal shock wave therapy on plantar fasciitis in patients with axial spondyloarthritis: a double-blind, randomized controlled trial11
The impact of the ongoing COVID-19 pandemic on the management of rheumatic disease: a national clinician-based survey10
YouTube as a source of information on COVID-19 vaccination in rheumatic diseases10
Factors associated with high cardiovascular risk in psoriatic arthritis and non-psoriatic spondyloarthritis10
Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study9
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study9
Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials8
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls8
Patients with rheumatic diseases are ready to use social media in clinical practice; what about rheumatologists? A cross-sectional survey8
0.081812143325806